GIP (glucose-dependent insulinotropic polypeptide) Agonist

[ jee-i-pee a-guh-nuhst ]

GIP agonists are a type of medication used to treat type 2 diabetes. GIP, or glucose-dependent insulinotropic polypeptide, is a hormone that stimulates the production and release of insulin from the pancreas in response to food intake. GIP agonists work by mimicking the action of GIP and increasing insulin production, which helps to lower blood sugar levels. In addition to its effect on insulin secretion, GIP also promotes the growth and survival of pancreatic beta cells, which are responsible for producing insulin. Therefore, GIP agonists may also have a protective effect on the pancreas and help to preserve beta cell function in patients with type 2 diabetes.